AstraZeneca PLC (AZN)
(Delisted)LSE
12,234.00
0.00 (0.00%)
Closed
Aug 26, 2026
Day's Range
12,214.0012,464.00
52 wk Range
9,892.0015,732.00
Financial Statements - AZN - AstraZeneca PLC
Revenue
58.73B▲ 47.9%
Net Income
10.23B▲ 97.8%Net Margin 17.4%
EBITDA
19.13B▲ 67.1%
Free Cash Flow
8.67B▲ 62.2%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Sales | 58.73B | 39.72B | 45.81B | 44.35B | 37.41B | 26.61B |
| Cost of Goods | 10.63B | 7.49B | 8.26B | 12.39B | 12.43B | 5.29B |
| Gross Profit | 48.10B | 32.22B | 37.54B | 31.96B | 24.98B | 21.31B |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | 13.32B | 7.53B | 8.72B | 4.51B | -139M | 3.91B |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | - | - | - | - | - | - |
| Pre Tax Income | 12.40B | 6.38B | 6.89B | 2.50B | -265M | 3.91B |
| Income Tax | 2.16B | 1.21B | 938M | -792M | -380M | 772M |
| Net Income | 10.23B | 5.17B | 5.96B | 3.29B | 115M | 3.14B |
| EPS Basic | 6.6 | 4.54 | 3.84 | 2.12 | 0.08 | 2.44 |
| EPS Diluted | 6.54 | 4.5 | 3.81 | 2.11 | 0.08 | 2.44 |
| Basic Shares Outstanding | 1.55B | 1.13B | 1.91B | 1.91B | 1.75B | 1.62B |
| Diluted Shares Outstanding | 1.55B | 1.13B | 1.91B | 1.91B | 1.75B | 1.62B |
| Ebit | 14.01B | 7.61B | 8.48B | 3.83B | 1.01B | 5.18B |
| Ebitda | 19.13B | 11.45B | 13.91B | 9.82B | 3.92B | 6.83B |
| Net Income Continuous Operations | 12.40B | 6.38B | 6.89B | 2.50B | -265M | 3.91B |
| Minority Interests | -8M | -6M | -6M | -5M | -3M | 52M |
| Preferred Stock Dividends | 0 | 0 | 0 | 0 | 0 | 0 |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
